Michael Leek
Chief Executive Officer en TC Biopharm Ltd. .
Perfil
Michael Leek is the founder and Chief Executive Officer of TC Biopharm Ltd., a position he has held since 2014.
He was also the founder of TC Biopharm (Holdings) Plc, where he served as the Chief Technology Officer in 2023.
Dr. Leek is also the founder of TCB Newco Ltd.
In his former job, he worked at Intercytex Ltd.
from 2000 to 2006, holding the position of Vice President-Operations.
Dr. Leek obtained a doctorate degree from the University of Leeds.
Cargos activos de Michael Leek
| Empresas | Cargo | Inicio |
|---|---|---|
TC Biopharm Ltd.
 TC Biopharm Ltd. Miscellaneous Commercial ServicesCommercial Services TC Biopharm Ltd. provides research services. The firm specializes in clinical grade cell therapy, cancer immonotherapy, regenerative medicine, and stratified medicine. The company was founded by Michael Leek, Angela Scott and David Galagher in 2014 and is headquartered in Edinburgh, the United Kingdom. | Chief Executive Officer | 01/01/2014 |
TCB Newco Ltd.
 TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Chief Executive Officer | - |
Antiguos cargos conocidos de Michael Leek.
| Empresas | Cargo | Fin |
|---|---|---|
| TC BIOPHARM (HOLDINGS) PLC | Chief Executive Officer | 01/06/2021 |
Intercytex Ltd.
 Intercytex Ltd. Pharmaceuticals: MajorHealth Technology The company is developing cell-based treatments for skin and hair regeneration. Its TrichoCyte product candidate is injected just beneath the scalp to encourage new hair follicles to form. Another product candidate, ProtoDerm, could treat diabetic ulcers and other chronic dermal wounds. | Chief Operating Officer | 03/02/2006 |
Formación de Michael Leek.
| University of Leeds | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| TC BIOPHARM (HOLDINGS) PLC | Health Technology |
| Empresas privadas | 3 |
|---|---|
Intercytex Ltd.
Intercytex Ltd. Pharmaceuticals: MajorHealth Technology The company is developing cell-based treatments for skin and hair regeneration. Its TrichoCyte product candidate is injected just beneath the scalp to encourage new hair follicles to form. Another product candidate, ProtoDerm, could treat diabetic ulcers and other chronic dermal wounds. | Health Technology |
TC Biopharm Ltd.
TC Biopharm Ltd. Miscellaneous Commercial ServicesCommercial Services TC Biopharm Ltd. provides research services. The firm specializes in clinical grade cell therapy, cancer immonotherapy, regenerative medicine, and stratified medicine. The company was founded by Michael Leek, Angela Scott and David Galagher in 2014 and is headquartered in Edinburgh, the United Kingdom. | Commercial Services |
TCB Newco Ltd.
TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Health Technology |
- Bolsa de valores
- Insiders
- Michael Leek
